Paula and Bobby
Parents of Lillie
Chromosome 1q21.1 – Microdeletion
What is Chromosome 1q21.1 – Microdeletion?
This rare disease is a genetic syndrome that occurs due to microdeletions on a specific chromosome.
It affects the development of affected individuals, especially their motor skills development.
Some individuals diagnosed with microdeletion show no symptoms of the syndrome at all, the reasons for this are still being researched.
There are less than 50 reported cases of the syndrome worldwide, to date.
What gene changes cause Chromosome 1q21.1 – Microdeletion?
The syndrome occurs when small pieces of DNA are deleted from chromosome 1 in each cell.
It is inherited in an autosomal dominant pattern, and about 50% of cases are inherited.
In the case of autosomal dominant inheritance just one parent is the carrier of the gene mutation, and they have a 50% chance of passing it onto each of their children. Syndromes inherited in an autosomal dominant inheritance are caused by just one copy of the gene mutation.
Microdeletion inheritance occurs when there is a deletion of several genes on a chromosome. The specific chromosome on which the deletions occur will determine the syndrome they cause.
What are the main symptoms of Chromosome 1q21.1 – Microdeletion?
75% of children with the syndrome will have developmental delay. This generally affects the development of their motor skills but is often mild in most cases.
Facial features associated with this syndrome are a prominent forehead, a large rounded nasal tip, a long philtrum, high arched palate, a very small head, short stature and cataracts (a clouding of the lens).
Seizures and hypotonia (low muscle tone) are also reasonably common symptoms of the syndrome.
Some individuals experience behavioral conditions, including ADHD, autism spectrum disorder. Individuals with the syndrome may also be at higher risk of developing schizophrenia.
How does someone get tested for Chromosome 1q21.1 – Microdeletion?
The initial testing for Chromosome 1q21.1 - Microdeletion syndrome can begin with facial analysis screening, through the FDNA Telehealth telegenetics platform, which can identify the key markers of the syndrome and outline the need for further testing. A consultation with a genetic counselor and then a geneticist will follow.
Based on this clinical consultation with a geneticist, the different options for genetic testing will be shared and consent will be sought for further testing.
What is FDNA Telehealth?
FDNA Telehealth is a leading digital health company that provides faster access to accurate genetic analysis.
With a hospital technology recommended by leading geneticists, our unique platform connects patients with genetic experts to answer their most pressing questions and clarify any concerns they may have about their symptoms.
Benefits of FDNA Telehealth
Our platform is currently used by over 70% of geneticists and has been used to diagnose over 250,000 patients worldwide.
FDNA Telehealth provides facial analysis and screening in minutes, followed by fast access to genetic counselors and geneticists.
Ease of Use
Our seamless process begins with an initial online diagnosis by a genetic counselor and follows by consultations with geneticists and genetic testing.
Accuracy & Precision
Advanced artificial intelligence (AI) capabilities and technology with a 90% accuracy rate for a more accurate genetic analysis.
Faster access to genetic counselors, geneticists, genetic testing, and a diagnosis. As fast as within 24 hours if required. Save time and money.
Privacy & Security
We guarantee the utmost protection of all images and patient information. Your data is always safe, secure, and encrypted.